FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Rep. Kim Reintroduces Drug Recall Authority Bill

[ Price : $8.95]

U.S. Representative Andy Kim (D-NJ) reintroduces a bill to provide FDA with mandatory recall authority for any and all faulty or u...

Florida Gets $600K in Cochlear Implants Case

[ Price : $8.95]

Florida wins a $600,000 payment to the states Medicaid program under a multistate action against cochlear implants maker Advanced ...

FDA Explores AI Image Analysis for Complex Drugs

[ Price : $8.95]

FDA explores whether it can enter into a five-year contract with an entity that can perform non-invasive high-resolution imaging a...

Boost Faith in Accelerated Approvals: Researchers

[ Price : $8.95]

Yale University researchers suggest five steps FDA could consider to help build patient and clinician trust in drug accelerated ap...

RSVpreF Vaccine Meets Endpoints

[ Price : $8.95]

Pfizer-supported research shows its investigational bivalent RSV prefusion F protein-based vaccine succeeded in preventing RSV-ass...

Mutagenic Impurities Guideline Adopted

[ Price : $8.95]

The International Council for Harmonization gives final approval to a guidance on assessing and controlling mutagenic impurities i...

FDA Wants MDUFA 5 PPI Input

[ Price : $8.95]

FDA asks for input on five questions that could be included in a revision of a medical device patient perspective guidance.

Comments Extended on Neurodevelopmental Study Guide

[ Price : $8.95]

Federal Register notice: FDA extends the comment period for a draft guidance entitled Considerations for Long-Term Clinical Neurod...

Untitled Letter Sent to Fidia Pharma

[ Price : $8.95]

CBER issues an untitled letter to Fidia Pharma USA after reviewing the companys Web sites and determining that its cell/tissue pro...

Guide on Clinical Outcome Assessments

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance on incorporating clinical outcome assessments into endpoints.